Internal Medicine, Gastroenterology · Rosemead, CA
NPI
1376570184
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
9143 Valley Blvd, 203
Rosemead, CA, 91770
Phone (626) 285-7598
Medicare paid, 2024
$61K
621 services
Medicare patients, 2024
335
Average age 73
Drug cost, 2024
$1.3M
1,688 prescriptions
Company payments, 2025
$14.97
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tu Tranvan was code 99213 (office e&m - established), 232 times for 152 patients. In total Tu Tranvan billed 621 services in 11 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 232 | 152 | $70.79 | $16K |
| 99203 Office E&M - New | Office | 153 | 153 | $81.54 | $12K |
| 45380 Lower GI Endoscopy - Other | Facility | 58 | 58 | $139.47 | $8,089 |
| 43239 Upper GI Endoscopy | Facility | 48 | 48 | $89.56 | $4,299 |
| 99214 Office E&M - Established | Office | 26 | 24 | $95.19 | $2,475 |
| 45385 Colonoscopy - Lesion Removal | Facility | 25 | 25 | $219.79 | $5,495 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 22 | 22 | $188.87 | $4,155 |
| 45378 Lower GI Endoscopy - Other | Facility | 22 | 22 | $150.77 | $3,317 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 13 | 13 | $188.50 | $2,450 |
| 99204 Office E&M - New | Office | 12 | 12 | $130.84 | $1,570 |
By year: 2022 $64K for 690 services; 2023 $54K for 534 services; 2024 $61K for 621 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tu Tranvan prescribed most often to Medicare patients was Vemlidy (Tenofovir Alafenamide), with 657 prescriptions and refills. In total Tu Tranvan wrote 1,688 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vemlidy Tenofovir Alafenamide | 657 | 679 | 62 | $946K |
| Entecavir Generic | 296 | 461 | 47 | $56K |
| Pantoprazole Sodium Generic | 197 | 247 | 63 | $759 |
| Linzess Linaclotide | 109 | 109 | 28 | $56K |
| Famotidine Generic | 89 | 104 | 32 | $569 |
| Lansoprazole Generic | 46 | 56 | 23 | $507 |
| Hydrocortisone Generic | 39 | 43 | 17 | $440 |
| Omeprazole Generic | 33 | 41 | 11 | $217 |
| Procto-Med Hc Hydrocortisone | 25 | 25 | 11 | $220 |
| Tenofovir Disoproxil Fumarate Generic | 24 | 42 | Under 11 | $1,927 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 17 | 17 | Under 11 | $373 |
| Voquezna Vonoprazan Fumarate | 13 | 19 | Under 11 | $12K |
| Triamcinolone Acetonide Generic | 13 | 18 | Under 11 | $166 |
| Creon Lipase/Protease/Amylase | 13 | 13 | Under 11 | $19K |
| Lactulose Generic | 11 | 11 | Under 11 | $157 |
Brand drugs: 813 claims; generic drugs: 875 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tu Tranvan $14.97 ($14.97 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $14.97.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $14.97 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.